CARMA LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
CARMA LABORATORIES, INC. holds 60 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 56 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 22 trademarks are registered. Notable registered marks include 3 IN 1, CARMEX, CLICK STICK, MOISTURE SHIELD, and CARMEX DAILY CARE. The owner is based in FRANKLIN, WI.
5801 WEST AIRWAYS AVENUE
FRANKLIN, WI 53132
Showing of trademarks Trademarks
Trademark Classifications
CARMA LABORATORIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does CARMA LABORATORIES, INC. have?
CARMA LABORATORIES, INC. has 60 U.S. trademarks filed with the USPTO. Of these, 22 registered, 23 abandoned, 15 cancelled.
What trademark classes does CARMA LABORATORIES, INC. file in?
CARMA LABORATORIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CARMA LABORATORIES, INC.'s most well-known trademarks?
CARMA LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as 3 IN 1, CARMEX, CLICK STICK, MOISTURE SHIELD, and CARMEX DAILY CARE. These are among 22 currently registered trademarks in the portfolio.
What is CARMA LABORATORIES, INC.'s trademark registration success rate?
CARMA LABORATORIES, INC. has a 37% trademark registration rate, with 22 out of 60 resolved applications resulting in successful registration. Currently, 0 applications are pending review.